Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 28, 2012

View Archived Issues

New approach for the rational and automated design of ligands against multiple drug targets

Sunovion Pharmaceuticals synthesizes new mGlu5 receptor modulators

Neuren Pharmaceuticals to conduct phase II trial of NNZ-2566 in Rett syndrome

U.K. researchers develop novel model of B-cell and myeloid malignancies

Forest and Glenmark to develop agents for chronic inflammatory conditions

Takeda and Amylin terminate worldwide agreement

AMAG Pharmaceuticals files sNDA for Feraheme

Favorable results presented for BC-2059, a novel beta-catenin inhibitor

NewGen Therapeutics discloses novel PARP-1 inhibitors

Japanese researchers patent new insulin secretagogues

Infinity Pharmaceuticals amends license agreement with Millennium

Daiichi Sankyo synthesizes new series of renin inhibitors

Covidien to acquire CV Ingenuity

Bristol-Myers Squibb prepares novel Abeta production inhibitors

Clinical trial notification accepted in Japan for phase I oral rigosertib trial

Study of voclosporin in uveitis does not meet primary endpoint

Ajinomoto Pharmaceuticals and Yoshindo to form joint venture

Otsuka obtains new approvals for carnitine deficiency treatments

Pfizer and Bristol-Myers Squibb obtain Japanese approval for novel anticoagulant

Neupro Patch approved in Japan for Parkinson's disease and restless legs syndrome

Japanese MHLW approves marketing application for Cimzia in RA

Japanese MHLW approves Novo Nordisk's combination therapy for diabetes

ABT-199 demonstrates antitumor activity in patients with NHL

Addex Therapeutics characterizes novel mGlu7 negative allosteric modulator

German researchers develop novel technique to study MM cell engraftment and progression

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...